GHRP-6

Overview

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide classified as a potent growth hormone secretagogue. It is widely studied in laboratory environments for its ability to stimulate the release of growth hormone by activating the ghrelin receptor (GHS-R) in preclinical models such as laboratory rodents. GHRP-6 is often used in research alongside GHRH analogs to examine synergistic effects on natural growth hormone pathways.

Benefits

Preclinical studies indicate that GHRP-6 may support increased natural growth hormone production, enhanced protein synthesis, improved tissue repair, and accelerated recovery in test subjects. Research has also shown its potential to significantly increase appetite in laboratory animals, making it useful in studies related to weight gain, nutrient absorption, and energy balance.
Source: Bowers CY, et al. GHRP-6: A potent stimulator of growth hormone release in humans. Endocrinology and Metabolism Clinics of North America, 1992.

Possible Side Effects

In laboratory research, test subjects administered GHRP-6 may show mild side effects such as temporary injection site irritation, increased appetite, mild water retention, or slight changes in blood sugar levels. Effects vary depending on dosage, frequency, and species used in the study.
Source: Bowers CY, et al., Endocrinol Metab Clin North Am, 1992.

Dosage & Administration

GHRP-6 is typically administered via subcutaneous injection following approved laboratory protocols. Common research dosages range from 100 mcg to 300 mcg per injection, often administered one to three times daily depending on the research design and species. It is frequently combined with GHRH analogs like Sermorelin to amplify growth hormone output in test models.
For laboratory research use only. Not for human consumption.

Summary

GHRP-6 is a synthetic growth hormone secretagogue peptide developed exclusively for research exploring natural growth hormone release, protein synthesis, and appetite stimulation in preclinical models. Studies suggest it may help elevate growth hormone levels and enhance appetite, with mild side effects such as increased hunger or injection site irritation occasionally observed in test subjects. GHRP-6 is typically administered by subcutaneous injection, with dosage and frequency adjusted to each study’s goals and test species.
Strictly for research purposes only. Not for human use.